US Patent Issued to Aligos Therapeutics on Oct. 28 for "Modified short interfering nucleic acid (siNA) molecules and uses thereof" (American, German Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,691, issued on Oct. 28, was assigned to Aligos Therapeutics Inc. (South San Francisco, Calif.).

"Modified short interfering nucleic acid (siNA) molecules and uses thereof" was invented by Leonid Beigelman (San Mateo, Calif.), Vivek Kumar Rajwanshi (Cupertino, Calif.), Markus Hossbach (Kulmbach, Germany), Rajendra K. Pandey (Foster City, Calif.), Jin Hong (Pacifica, Calif.), Laxman Eltepu (San Ramon, Calif.), Saul Martinez Montero (San Bruno, Calif.) and N. Tilani S. De Costa (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described are short interfering nucleic acid (siNA) molecules comprising modified nucleotides, compos...